---
$id: https://graph.org.ai/products/commodity/51111857
$type: Product
source: UNSPSC
code: "51111857"
title: "Lasofoxifene"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lasofoxifene

**UNSPSC Code**: 51111857
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a selective estrogen receptor modulator with the molecular formula C28H31NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 337G83N988, chemically known as 2-naphthalenol, 5,6,7,8-tetrahydro-6-phenyl-5-(4-(2-(1-pyrrolidinyl)ethoxy)phenyl)-, (5r-cis)- but generally known as lasofoxifene, which bears US NIH Compound Identifier 216416. European Medicines Agency schedules Lasofoxifene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB27754. The term LASOFOXIFENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 1, 2000, List 43). World Health Organization schedules lasofoxifene in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule lasofoxifene under HS 29339990 and SITC 51577. As of Q4 2014, LASOFOXIFENE remains the US FDA Preferred Term for this commodity. Lasofoxifene bears US NLM identifiers UMLS ID C0672898 and NCI Concept Code C80679. SMILES: O(CCN1CCCC1)C1CCC(C2C(CCC3C2CCC(O)C3)C2CCCCC2)CC1.

